Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00033020 · ClinicalTrials.gov registry record · Phase 3

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1

A Phase 3 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 3
Development phase
390
Enrollment target

NCT00033020: Completed Phase 3 study, sponsored by Johns Hopkins University.

NCT00033020 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 390 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00033020, a Phase 3 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 3
Development phase
390 participants
Enrollment target

Study Summary

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2001-04
Est. Completion 2003-02
Phase Phase 3

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00033020

The ClinicalTrials.gov registry entry for NCT00033020 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00033020 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00033020 about?

NCT00033020 is a clinical study titled "Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1". The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

What is the current status of trial NCT00033020?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 390 participants. The study started on 2001-04. Estimated completion is 2003-02.

What interventions are being tested in trial NCT00033020?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00033020?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.